Selexipag is a pharmaceutical raw material and a prodrug that is converted in the body to its active metabolite, ACT-333679. It is primarily used in the manufacturing of compounds targeting the prostacyclin receptor pathway for research and pharmaceutical applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Selexipag?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Sorafenib tosylate
pharmaceutical raw material
Adw-742
pharmaceutical raw material
GSK 621659A
pharmaceutical raw material
NVP-AEW541
pharmaceutical raw material
5-bromo-2,3-diphenylpyrazine
research compound
5-chloro-2,3-diphenylpyrazine
Research reagent
The international HS code for Selexipag (CAS 475086-01-2) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
QXWZQTURMXZVHJ-UHFFFAOYSA-N
CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3
Sourcing Selexipag?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.